Alivus Life Sciences Limited (BOM:543322)
1,066.80
+61.80 (6.15%)
At close: Mar 27, 2025
Alivus Life Sciences Statistics
Total Valuation
BOM:543322 has a market cap or net worth of INR 126.67 billion. The enterprise value is 122.37 billion.
Market Cap | 126.67B |
Enterprise Value | 122.37B |
Important Dates
The next estimated earnings date is Thursday, April 24, 2025.
Earnings Date | Apr 24, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.28% |
Shares Change (QoQ) | -0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 30.64M |
Valuation Ratios
The trailing PE ratio is 28.68.
PE Ratio | 28.68 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 5.02 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | 27.70 |
EV / Sales | 5.38 |
EV / EBITDA | 19.62 |
EV / EBIT | 21.55 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 0.01 |
Debt / EBITDA | 0.03 |
Debt / FCF | n/a |
Interest Coverage | 374.02 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Invested Capital (ROIC) | 14.30% |
Return on Capital Employed (ROCE) | n/a |
Revenue Per Employee | 11.29M |
Profits Per Employee | 2.19M |
Employee Count | 2,014 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +37.60% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | +37.60% |
50-Day Moving Average | 1,078.93 |
200-Day Moving Average | 1,036.61 |
Relative Strength Index (RSI) | 48.22 |
Average Volume (20 Days) | 5,568 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BOM:543322 had revenue of INR 22.74 billion and earned 4.42 billion in profits. Earnings per share was 35.93.
Revenue | 22.74B |
Gross Profit | 11.99B |
Operating Income | 5.68B |
Pretax Income | 5.93B |
Net Income | 4.42B |
EBITDA | 6.21B |
EBIT | 5.68B |
Earnings Per Share (EPS) | 35.93 |
Balance Sheet
The company has 4.46 billion in cash and 159.77 million in debt, giving a net cash position of 4.30 billion.
Cash & Cash Equivalents | 4.46B |
Total Debt | 159.77M |
Net Cash | 4.30B |
Net Cash Per Share | n/a |
Equity (Book Value) | 25.38B |
Book Value Per Share | 207.20 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 52.73%, with operating and profit margins of 24.97% and 19.42%.
Gross Margin | 52.73% |
Operating Margin | 24.97% |
Pretax Margin | 26.06% |
Profit Margin | 19.42% |
EBITDA Margin | 27.31% |
EBIT Margin | 24.97% |
FCF Margin | n/a |
Dividends & Yields
BOM:543322 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | -0.28% |
Shareholder Yield | -0.28% |
Earnings Yield | 3.49% |
FCF Yield | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |